About this trial
Sleep is essential for life and overall health. Unfortunately, a large portion of the population in the U.S. and worldwide experience sleep deficiencies, which increase their risk for developing chronic diseases. These sleep difficulties often cause distress, leading individuals to seek various forms of treatment. Given that some drugs cause habituation and undesirable side effects, individuals often turn to over-the-counter sleep remedies. However, long-term use of over-the-counter treatments is not recommended by the American Academy of Sleep Medicine for insomnia treatment and there is currently no recommendation related to dietary management. There is a strong need to identify natural measures to improve sleep in millions of adults battling poor sleep. Diet is emerging as a potentially important modulator of sleep. Despite observational data linking greater nut intake with better sleep, and that pistachios contain a significant number of sleep-promoting compounds, no study to date has evaluated the impact of pistachio supplementation on sleep. To address this key knowledge gap, the investigators propose to conduct a randomized controlled trial to evaluate the impact of pistachio consumption, relative to a calorie-matched control food, on sleep in middle-aged adults with poor sleep and to explore underlying mechanisms.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Poor sleep quality, Pittsburgh Sleep Quality Index score >5
BMI 20 - 29.9 kg/m²
Ability to abstain from travel across time zones
Willingness to eat study foods
Disqualifiers
Premenopausal women
Smoking
Excessive caffeine intake (>300 mg/day)
Non-day shift work
Trial design
Crossover
Treatments tested in this trial
Pistachio
Dietary supplement2 servings/day for 4 weeks (56 g total/day)
Control food
Dietary supplementMuffins and cookies (no nuts), at an equivalent number of calories as the pistachio intervention, daily
Treatment groups
Trial outcomes
Primary outcomes
Self-reported sleep quality
Self-reported sleep quality will be reported by the score on the Pittsburgh Sleep Quality Index. The full score range is 0 to 21, where a higher score indicates worse sleep quality.
Objective sleep quality
Sleep fragmentation index assessed by wrist actigraphy. This is a measure of how frequently sleep is interrupted, calculated as the sum of the percentage of all scored epochs with one or more activity counts during time in bed and percentage of one-minute periods of sleep vs all periods of sleep during the sleep period.
Overnight melatonin production
Amount of 6-sulfatoxymelatonin present in urine collected overnight, reported as ng/mg creatinine (corrected for creatinine content).
Secondary outcomes
Sleep efficiency
Percent of time in bed spent asleep from wrist actigraphy
Sleep depth
Time spent in deep sleep from home sleep test
Sleepiness
Sleepiness will be reported by the score on the Epworth Sleepiness Scale. The full score range is 0 - 10, where a higher score indicates greater sleepiness.
Insomnia symptoms
Insomnia symptoms will be assessed using the Insomnia Severity Index. The full score range is 0 - 28, where a higher score indicates more severe insomnia.
Other outcomes
Gut microbial diversity
Shannon index of alpha-diversity
Polyphenols
Total amount of polyphenols present in urine collected overnight
Polyphenol subtypes
Amount of each polyphenol subtype detected in urine collected overnight
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Columbia University
Lead sponsor
American Pistachio Growers
Collaborator